Reuters logo
Botox-maker Allergan quarterly revenue rises 9 pct
August 3, 2017 / 12:10 PM / 3 months ago

Botox-maker Allergan quarterly revenue rises 9 pct

Aug 3 (Reuters) - Drugmaker Allergan Plc posted a 9 percent rise in quarterly revenue, helped by strength in its medical aesthetics unit.

Net loss attributable to ordinary shareholders widened to $795.5 million, or $2.37 per share, in the second quarter ended June 30, from $571.3 million, or $1.44 per share, a year earlier.

Net revenue for the acquisitive Dublin-based company, which in February agreed to buy Zeltiq Aesthetics Inc, rose 9 percent to $4.01 billion.

Total medical aesthetics revenue rose to $643.9 million from $419.8 million. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Supriya Kurane)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below